Postprandial Glucose Levels, Gut Microbiota and Supplementation With Functional Foods in Adults (PPGR)
Healthy, Nutritional and Metabolic Diseases
About this trial
This is an interventional treatment trial for Healthy focused on measuring Postprandial glucose responses, Gut microbiota, Functional foods
Eligibility Criteria
Inclusion Criteria: Male and female Adults between 18 and 60 years of age. The signing of the informed consent. Exclusion Criteria: Patients with any type of diabetes. Patients with high blood pressure. Patients with acquired diseases secondarily producing obesity and diabetes. Patients who have suffered a cardiovascular event. Patients with gastrointestinal diseases. Weight loss > 3 kg in the last 3 months. Catabolic diseases such as cancer and acquired immunodeficiency syndrome. Pregnancy status. Drug treatment: Antihypertensive drugs or treatment (thiacycline, loop or potassium-sparing diuretics, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, alpha blockers, calcium antagonists, beta blockers). Treatment with hypoglycemic agents (sulfonylureas, biguanides, incretins) or insulin and antidiabetic drugs. Treatment with statins, fibrates or other drugs to control dyslipidemia. Use of antibiotics in the three months prior to the study. Use of steroid drugs, chemotherapy, immunosuppressants, or radiation therapy. Anorexigenic or that accelerate weight loss such as sibutramine or orlistat. Supplements with any of the functional foods used in the study. Probiotic, prebiotic or symbiotic supplements.
Sites / Locations
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránRecruiting
Arms of the Study
Arm 1
Experimental
Nutritional strategy based on functional foods
Participants will be provided with a nutritional strategy based on functional foods to use over the 2 week trial. These will be nopal, chía seeds, inulin, soy protein, agave extract and genistein.